Environmental, Social And Governance Report

Overview

The report covers HighTide Therapeutics' 2024 ESG performance across its headquarters and wholly-owned subsidiaries operating in China. It describes a Board-led ESG governance structure, a materiality assessment covering 22 issues, and a Board comprising eight directors, including two women representing 25%. Environmental disclosures report 50.14 tCO2e of total Scope 1 and Scope 2 GHG emissions and a long-term carbon-neutrality goal for 2060. The report also records zero work-related fatalities and zero product and service complaints during the reporting period.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview